AbbVie Inc.
ABBV 184.00 (-0.71%) 1.31
325.02(B)
Health Care
Biotechnology
My Holdings:
(?% ownership)
Shares:
Cost basis:
Market cap:$325.02(B)
EV:$398.69(B)
Total Equity:$1.46(B)
Div. yield:3.47%
Earnings date:Jul-25-2025
P/E:78.30
P/E (fwd):15.03
P/FCF:21.13
P/S:5.67
P/B:230.00
EPS:$2.4
EPS (fwd):$12.2
FCF/share:$8.7
Dividend/share:$6.4
Book value/share:$0.8
ROIC:5.5%
ROA:2.9%
ROE:89.0%
Jump to:ValuationTTM FinancialsGrowth EstimatesHistorical DataSimilar CompaniesOwnershipToolsSummary
ABBV Valuation & Price Targets
Current Price
PE Valuation
PEvaluation is not available for ABBV.
Analyst targets
No analyst estimates for ABBV.
DCF
Adjust your assumptions to reach a valid valuation.
DCF (exit mult.)
Adjust your assumptions to reach a valid valuation.
Future P/E
Adjust your assumptions to reach a valid valuation.
Peter Lynch FV
Adjust your assumptions to reach a valid valuation.
Graham No.
Adjust your assumptions to reach a valid valuation.
DDM
Adjust your assumptions to reach a valid valuation.
PEvaluation
14% overvalued
Low
$119
Mid
$159
High
$198
Current price
$184
Fair P/E
Margin of safety
Market Model
Economic moat: Wide
Analyst Price Targets
11% undervalued
Low
$170
Mid
$205
High
$250
Current price
$184
Estimated EPS
| Low | Avg | High | # | |
| FY+1 | 12.0 | 12.2 | 12.8 | 27 |
| FY+2 | 12.9 | 14.0 | 15.1 | 26 |
| FY+3 | 14.2 | 15.4 | 17.1 | 21 |
| FY+4 | 15.1 | 16.9 | 18.9 | 13 |
| FY+5 | 15.3 | 18.3 | 20.5 | 11 |
Discounted Cash Flow
| Forecast years | |
| Terminal Growth Rate | |
| Discount Rate |
Free cash flow estimates:
Discounted Cash Flow (exit mult.)
| Forecast years | |
| Exit FCF Multiple | |
| Discount Rate |
Free cash flow estimates:
Future P/E Valuation
| Projection Years | |
| Base Revenue | |
| Revenue Growth Rate | |
| Final Net Margin | |
| Final P/E Ratio | |
| Discount Rate |
Peter Lynch Fair Value
| Earnings Per Share | |
| Growth Rate (*) |
(*) Growth rate is capped between 0 and 25
Graham Formula
| Earnings Per Share | |
| Expected Growth Rate | |
| Government Bond Rate |
(*) Growth rate is capped to 25
Dividend Discount Model
| Annual Dividend | |
| First Stage Length (Years) | |
| First Stage Growth Rate | |
| Final Growth Rate | |
| Discount Rate |
(*) First stage rowth rate is capped to 20%
Based on 0 valuation methods, the average fair value estimate for ABBV is $N/A (NaN% overvalued).
Valuations range from $1.7976931348623157e+308 (N/A) to $0.0 (N/A).
TTM Financials
Income (TTM)
Revenue$57.37(B)
Gross profit$40.74(B)
EBITDA$27.37(B)
Net income$4.20(B)
Gross margin71.0%
Operating margin22.5%
Net margin7.3%
Shares outstanding:1.77(B)
Balance sheet
Total assets$136.16(B)
Current assets$27.68(B)
Total liabilities$134.70(B)
Current liabilities$36.40(B)
Cash & Short-term inv.$5.18(B)
Long-term debt$64.66(B)
Total intangibles$93.77(B)
PP&E$5.24(B)
Cash flow (TTM)
FCF$15.38(B)
CapEx$-1.02(B)
Dividends paid$-11.18(B)
Stock issued$143.00(M)
Stock repurchased$-1.34(B)
Stock-based comp.$1.48(B)
Debt issued$7.59(B)
Debt repaid$-12.54(B)
Per share data (TTM)
Growth Estimates
Revenue
CAGR: 6.5%FY+1$59.87(B)
FY+2(+8.0%)$64.64(B)
FY+3(+7.0%)$69.15(B)
FY+4(+6.4%)$73.60(B)
FY+5(+4.6%)$77.00(B)
Net Income
CAGR: 9.9%FY+1$21.73(B)
FY+2(+13.4%)$24.65(B)
FY+3(+10.6%)$27.27(B)
FY+4(+8.3%)$29.54(B)
FY+5(+7.4%)$31.74(B)
EPS
CAGR: 10.6%FY+1$12.24
FY+2(+14.1%)$13.96
FY+3(+10.2%)$15.39
FY+4(+9.7%)$16.89
FY+5(+8.3%)$18.29
FCF per share
CAGR: 12.1%FY+1$12.85
FY+2(+15.5%)$14.84
FY+3(+12.9%)$16.75
FY+4(+12.7%)$18.88
FY+5(+7.3%)$20.26
Historical Financials
Showing limited histrical data. Access 10+ years of financials now! Upgrade
Income
| FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | TTM | 5Y avg | 5Y CAGR | |
| Revenue | 45.80(B) | 56.20(B) | 58.05(B) | 54.32(B) | 56.33(B) | 57.37(B) | 54.14(B) | 5% | |||||||||||
| COGS | 15.39(B) | 17.45(B) | 17.41(B) | 20.41(B) | 16.90(B) | 16.81(B) | 17.51(B) | 2% | |||||||||||
| Gross Profit | 30.42(B) | 38.75(B) | 40.64(B) | 33.90(B) | 39.43(B) | 40.55(B) | 36.63(B) | 7% | |||||||||||
| Total OpEx. | 19.05(B) | 20.83(B) | 21.83(B) | 20.37(B) | 27.54(B) | 27.64(B) | 21.92(B) | 10% | |||||||||||
| R&D | 7.75(B) | 8.05(B) | 6.51(B) | 7.67(B) | 12.79(B) | 12.92(B) | 8.56(B) | 13% | |||||||||||
| SG&A | 11.30(B) | 12.35(B) | 15.26(B) | 12.87(B) | 14.75(B) | 14.73(B) | 13.31(B) | 7% | |||||||||||
| Operating Income | 11.36(B) | 17.92(B) | 18.81(B) | 13.54(B) | 11.89(B) | 12.91(B) | 14.71(B) | 1% | |||||||||||
| Interest Expense | -2.45(B) | -2.42(B) | -2.23(B) | -2.22(B) | -2.81(B) | -2.85(B) | -2.43(B) | 3% | |||||||||||
| Interest Income | 174.00(M) | 39.00(M) | 186.00(M) | 540.00(M) | 648.00(M) | 514.00(M) | 317.40(M) | 39% | |||||||||||
| Pre-tax income | 3.40(B) | 12.99(B) | 13.48(B) | 6.25(B) | 3.72(B) | 3.62(B) | 7.97(B) | 2% | |||||||||||
| Income tax | 1.22(B) | -1.44(B) | -1.63(B) | -1.38(B) | 570.00(M) | 581.00(M) | -531.00(M) | -17% | |||||||||||
| Net Income | 4.62(B) | 11.54(B) | 11.84(B) | 4.86(B) | 4.28(B) | 4.20(B) | 7.43(B) | -2% |
Cash flow
Stock-based Comp.FCFCFONet IncomeD&ACFFStock IssuedStock RepurchasedDebt IssuedDebt RepaidDividend PaidCFIAcquisitionsDivestituresCapital Expenditures
Balance sheet
Total AssetsTotal LiabilitiesCurrent assetsCash and EquivalentsShort-term investmentsInventoriesReceivablesNon-current assetsNet PP&EIntangible AssetsGoodwillCurrent liabilitiesAccounts payableNon-current liabilitiesLong-Term DebtTotal Equity
Per share data
EPS (Basic)FCF/ShareDividend/ShareEPS (Diluted)Book value/ShareCash & ST inv./ShareDebt/Share
Ratios
P/EP/SEV/EarningsP/FCFP/BEV/FCFDebt/EquityPayout ratio
Margins
Net Income MarginOperating MarginGross MarginEBITDA MarginFCF Margin
Returns
ROICROAROCEROE
Shares outstanding
Shares (Basic)Shares (Diluted)
Market Cap.
Market Cap.
Similar Companies
Ownership
Major holders
Insiders: 0.10%
Institutions: 74.46%
Other: 25.43%
Institutions: 74.46%
Other: 25.43%
Institutional ownership
Insider transactions
Show:
Buys
Sells
Grants
| Date | Shares | Total ($) | Price ($) | Name | Title | |
| Grant | 2025-05-09 | 1,203 | 0 | 0.0 | FREYMAN THOMAS C | Director |
| Grant | 2025-05-09 | 1,203 | 0 | 0.0 | FALK THOMAS J | Director |
| Grant | 2025-05-09 | 1,203 | 0 | 0.0 | AUSTIN ROXANNE SCHUH | Director |
| Grant | 2025-05-09 | 1,203 | 0 | 0.0 | TILTON GLENN FLETCHER | Director |
| Grant | 2025-05-09 | 1,203 | 0 | 0.0 | WADDELL FREDERICK H | Director |
| Grant | 2025-05-09 | 1,203 | 0 | 0.0 | RAPP EDWARD J | Director |
| Grant | 2025-05-09 | 1,203 | 0 | 0.0 | ALPERN ROBERT J | Director |
| Grant | 2025-05-09 | 1,203 | 0 | 0.0 | HART BRETT J | Director |
| Grant | 2025-05-09 | 1,203 | 0 | 0.0 | BURNSIDE WILLIAM H L | Director |
| Grant | 2025-05-09 | 1,203 | 0 | 0.0 | MEYER MELODY B | Director |
| Grant | 2025-05-09 | 1,203 | 0 | 0.0 | ROBERTS REBECCA B. | Director |
| Grant | 2025-05-09 | 1,203 | 0 | 0.0 | DAVIS JENNIFER L | Director |
| Grant | 2025-05-09 | 1,203 | 0 | 0.0 | QUAGGIN SUSAN E | Director |
| Grant | 2025-03-31 | 2,450 | 0 | 0.0 | GONZALEZ RICHARD A | Director |
| Sell | 2025-03-31 | 58,832 | 12,359,504 | 210.1 | STEWART JEFFREY RYAN | Officer |
| Grant | 2025-03-31 | 25,700 | 2,030,814 | 79.0 | STEWART JEFFREY RYAN | Officer |
| Sell | 2025-03-14 | 17,644 | 3,746,527 | 212.3 | REENTS SCOTT T. | Chief Financial Officer |
| Sell | 2025-03-03 | 98,628 | 20,263,020 | 205.4 | GONZALEZ RICHARD A | Director |
| Sell | 2025-03-03 | 21,250 | 4,472,039 | 210.4 | RICHMOND TIMOTHY J | Officer |
| Sell | 2025-03-03 | 27,900 | 5,822,402 | 208.7 | SIATIS PERRY C. | General Counsel |
| Grant | 2025-03-03 | 18,008 | 2,879,040 | 159.9 | SIATIS PERRY C. | General Counsel |
| Sell | 2025-02-26 | 29,917 | 6,070,036 | 202.9 | RICHMOND TIMOTHY J | Officer |
| Grant | 2025-02-26 | 22,210 | 2,539,936 | 114.4 | RICHMOND TIMOTHY J | Officer |
| Sell | 2025-02-26 | 18,944 | 3,853,372 | 203.4 | BUCKBEE KEVIN K | Officer |
| Grant | 2025-02-26 | 16,260 | 1,601,313 | 98.5 | BUCKBEE KEVIN K | Officer |
| Sell | 2025-02-20 | 5,778 | 1,143,453 | 197.9 | SIATIS PERRY C. | General Counsel |
| Grant | 2025-02-13 | 171,837 | 0 | 0.0 | GONZALEZ RICHARD A | Director |
| Grant | 2025-02-13 | 38,154 | 0 | 0.0 | RICHMOND TIMOTHY J | Officer |
| Grant | 2025-02-13 | 38,498 | 0 | 0.0 | SALEKI-GERHARDT AZITA | Chief Operating Officer |
| Grant | 2025-02-13 | 61,362 | 0 | 0.0 | MICHAEL ROBERT A. | Chief Executive Officer |
| Grant | 2025-02-13 | 45,651 | 0 | 0.0 | STEWART JEFFREY RYAN | Officer |
| Grant | 2025-02-13 | 25,345 | 0 | 0.0 | DONOGHOE NICHOLAS | Officer |
| Grant | 2025-02-13 | 24,763 | 0 | 0.0 | REENTS SCOTT T. | Chief Financial Officer |
| Grant | 2025-02-13 | 17,762 | 0 | 0.0 | SIATIS PERRY C. | General Counsel |
| Grant | 2025-02-13 | 8,347 | 0 | 0.0 | BUCKBEE KEVIN K | Officer |
| Grant | 2025-02-13 | 10,555 | 0 | 0.0 | THAKKAR ROOPAL | Officer |
| Sell | 2024-12-16 | 1,800 | 310,032 | 172.2 | BUCKBEE KEVIN K | Officer |
| Grant | 2024-12-16 | 1,800 | 168,300 | 93.5 | BUCKBEE KEVIN K | Officer |
| Grant | 2024-09-30 | 57,670 | 0 | 0.0 | GONZALEZ RICHARD A | Officer and Director |
| Grant | 2024-09-24 | 25,630 | 0 | 0.0 | SALEKI-GERHARDT AZITA | Chief Operating Officer |
| Sell | 2024-08-05 | 66,500 | 12,403,580 | 186.5 | GONZALEZ RICHARD A | Officer and Director |
| Sell | 2024-07-17 | 282,845 | 49,497,875 | 175.0 | GONZALEZ RICHARD A | Officer and Director |
| Grant | 2024-07-17 | 282,845 | 21,919,048 | 77.5 | GONZALEZ RICHARD A | Officer and Director |
| Grant | 2024-06-28 | 6,000 | 0 | 0.0 | GONZALEZ RICHARD A | Chief Executive Officer |
Tools
Dividend Income
| Investment Amount | |
| Dividend Yield |
What is the Dividend Income Calculator?
The Dividend Income Calculator helps you estimate the yearly, quarterly, monthly, and daily income of your investments.
How to Use This Calculator?
Enter the dividend yield and the invested amount. Optionally, preload stock data to automatically fetch the dividend yield.
Required Investment
| Dividend Yield | |
| Desired Yearly Payout | |
| Desired Quarterly Payout | |
| Desired Monthly Payout |
What is the Required Investment Calculator?
The Required Investment Calculator helps you determine the amount of money you need to invest in a stock to achieve a desired dividend.
How to Use This Calculator?
Enter the dividend yield and your desired dividend income. Optionally, preload stock data to automatically fetch the dividend yield.
Future Dividend Yield
| Base Dividend | |
| Current Price | |
| Number of Years | |
| Dividend Growth Rate |
What is the Future Yield Calculator?
The Future Yield Calculator helps you estimate the future dividend yield of a stock based on its current dividend, price, and expected dividend growth rate.
How to Use This Calculator?
Enter the base dividend, current price, number of years, and dividend growth rate. Optionally, preload stock data to automatically fetch the dividend and price. The calculator will display the current yield and the projected future yield.